Document ID: chunk:federal_register_of_legislation:F2023L01702:clause:1_12
Version: federal_register_of_legislation:F2023L01702
Segment Type: clause
Provision Reference: sch 1 cl 12
Character Range: 7164–8341

12  Schedule 1 (table)
After:
Salbutamol  Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30  Inhalation  Salbutamol AN  between 1 December 2023 and 31 January 2024—0 months stock by reference to usual demand

insert:
Salbutamol  Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)  Inhalation by Mouth  Asmol CFC-Free with dose counter     between 1 January 2024 and 30 June 2024—0 months stock by reference to usual demand
Salbutamol  Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)  Inhalation by Mouth  Zempreon CFC-Free with dose counter  between 1 January 2024 and 30 June 2024—0 months stock by reference to usual demand

13 Schedule 1 (table)
After:
Tacrolimus  Capsule 5 mg  Oral  Tacrograf  3 months stock by reference to usual demand

insert:
Telmisartan  Tablet 40 mg  Oral  Telmisartan-DRLA  between 1 January 2024 and 29 February 2024—0 months stock by reference to usual demand
Telmisartan  Tablet 80 mg  Oral  Telmisartan-DRLA  between 1 January 2024 and 29 February 2024—0 months stock by reference to usual demand